Identifying patient‐important outcomes in polycystic kidney disease: An international nominal group technique study
Yeoungjee Cho, Allison Tong(The University of Sydney), Karine Manera(The University of Sydney), Albert Ong(University of Sheffield), Tess Harris(Polycystic Kidney Disease Foundation), Curie Ahn(Seoul National University), Bénédicte Sautenet(Université de Tours), Jonathan C. Craig(Flinders University), Gopala K. Rangan(Westmead Hospital), Talia Gutman(The University of Sydney), David W. Johnson(Hennepin County), York Pei(University Health Network), Armando Teixeira‐Pinto(The University of Sydney), Yun Kyu Oh(Seoul National University), Jessica Ryan(Monash Medical Centre), Helen Coolican(Kidney Health Australia), Vicente E. Torres(Mayo Clinic in Arizona), Andrea K. Viecelli(The University of Queensland), Charlotte Logeman(The University of Sydney), Martin Howell(UNSW Sydney), Ronald D. Perrone(Tufts Medical Center), Hyunsuk Kim(Seoul National University Hospital), Peter G. Kerr(Monash Health), Juliana T‐W Kao(Fu Jen Catholic University), Angela Ju(The University of Sydney), Claire Geneste(Université de Tours), Ron T. Gansevoort(University Medical Center Groningen), Arlene B. Chapman(Emory University), Yaerim Kim(Seoul National University)
Cited by 33
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
|Annals of Internal Medicine|2003|4.6k
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
|Kidney International|2010|2.3k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k